AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33156242 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched chain amino acids (BCAA) concentrations at 48 hours
Number of subjects: 228
Study 33156242 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched chain amino acids (BCAA) concentrations
Number of subjects: 228
Study 33156242 — intervention group
Group type: EXPERIMENTAL
Intervention: Valine, leucine, and isoleucine (BCAAs)
Number of subjects: 228
Study 33156242 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressor free days
Number of subjects: 228
Study 32167712 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Wallace anastomotic technique
Number of subjects: 140
Study 32167712 — intervention group
Group type: COMPARATOR
Intervention: Traditional ileal conduit
Number of subjects: 140
Study 34182157 — intervention group
Group type: EXPERIMENTAL
Intervention: CARES smartphone app
Number of subjects: 250
Study 34182157 — intervention group
Group type: COMPARATOR
Intervention: Existing online alcohol education (AE) program
Number of subjects: 250
Study 32904579 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Selected Training Intensity (SSTI) performed three times per week, 30-50 minutes per session (n=20)
Number of subjects: 40
Study 32904579 — intervention group
Group type: COMPARATOR
Intervention: Control group participated in health education meetings once per week (n=20)
Number of subjects: 40
Study 35938330 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 68
Study 35938330 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine protocol)
Number of subjects: 68
Study 33909662 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused ultrasound cavitation and moderate aerobic exercise for three months
Number of subjects: 34
Study 33909662 — intervention group
Group type: COMPARATOR
Intervention: Moderate aerobic exercise only
Number of subjects: 34
Study 32799029 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBTI)
Number of subjects: 113
Study 32799029 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep restriction therapy (SRT)
Number of subjects: 113
Study 32799029 — intervention group
Group type: COMPARATOR
Intervention: Sleep education control
Number of subjects: 113
Study 35413873 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride (SDF) treatment
Number of subjects: 160
Study 35413873 — intervention group
Group type: COMPARATOR
Intervention: Standard package of glass ionomer sealants and atraumatic restorative treatment (ART)
Number of subjects: 160
Study 35413873 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SDF and standard treatment
Number of subjects: 160
Study 33135283 — intervention group
Group type: EXPERIMENTAL
Intervention: Comic
Number of subjects: 151
Study 33135283 — intervention group
Group type: COMPARATOR
Intervention: Video
Number of subjects: 151
Study 33135283 — intervention group
Group type: COMPARATOR
Intervention: Brochure
Number of subjects: 151
Study 32398581 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion
Number of subjects: 144
Study 32398581 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg wrapping
Number of subjects: 144
Study 32398581 — intervention group
Group type: COMPARATOR
Intervention: Control (sham leg wrapping and saline infusion)
Number of subjects: 144
Study 36160639 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline + Lorcaserin
Number of subjects: 84
Study 36160639 — intervention group
Group type: COMPARATOR
Intervention: Varenicline + Placebo
Number of subjects: 84
Study 34553463 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract (300 mg twice daily)
Number of subjects: 100
Study 34553463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 34058041 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (anodal left primary motor cortex stimulation, 2 mA, 20 min, 36 patients)
Number of subjects: 77
Study 32051393 — intervention group
Group type: EXPERIMENTAL
Intervention: Gankyrin knockdown
Number of subjects: 256
Study 32051393 — intervention group
Group type: EXPERIMENTAL
Intervention: CCR3 inhibitor SB328437
Number of subjects: 256
Study 32051393 — intervention group
Group type: COMPARATOR
Intervention: Gankyrin overexpression
Number of subjects: 256
Study 32051393 — intervention group
Group type: COMPARATOR
Intervention: Gankyrin and STAT3 or CCL24 expression
Number of subjects: 256
Study 35310186 — intervention group
Group type: EXPERIMENTAL
Intervention: Crizotinib combined with chemotherapy (EG)
Number of subjects: 90
Study 35310186 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (CG)
Number of subjects: 90
Study 33793050 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg vitamin C from drink
Number of subjects: 10
Study 33793050 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg vitamin C from kiwifruit
Number of subjects: 10
Study 33793050 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 10
Study 32609534 — intervention group
Group type: EXPERIMENTAL
Intervention: Goreisan (2.5 g orally on the night before surgery and on the morning of surgery)
Number of subjects: 50
Study 32609534 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Goreisan)
Number of subjects: 50
Study 36029876 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 1864
Study 36029876 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 1864
Study 36029876 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1864
Study 36029876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1864
Study 36029876 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1864
Study 36029876 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials 1 and 2 (combined)
Number of subjects: 1864
Study 32607598 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg riluzole
Number of subjects: 52
Study 32607598 — intervention group
Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 52
Study 36014824 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation
Number of subjects: 345
Study 33145897 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs evaluating outcomes relevant to children's oral health; specific interventions not available.
Number of subjects: 0
Study 34801112 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ Vaccine (1.8 x 10^6 PfSPZ)
Number of subjects: 176
Study 34801112 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 176
Study 33638976 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric TB therapy
Number of subjects: 850
Study 33638976 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 850
Study 34510395 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral supplementation with sucrosomial magnesium associated with therapeutic exercise
Number of subjects: 0
Study 34510395 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic exercise only
Number of subjects: 0
Study 32221582 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744
Study 35670271 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual inspection (VIS)
Number of subjects: 205
Study 35670271 — intervention group
Group type: COMPARATOR
Intervention: Visual + radiographic (RAD) assessment
Number of subjects: 205
Study 33512679 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic cancer vaccines, specific details not available.
Number of subjects: 0
Study 33512679 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination partners (e.g., checkpoint inhibitors), specific details not available.
Number of subjects: 0
Study 33512679 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized, phase 3 studies of therapeutic cancer vaccines, specific details not available.
Number of subjects: 0
Study 33238244 — intervention group
Group type: EXPERIMENTAL
Intervention: Graston Technique® (GT)
Number of subjects: 23
Study 33238244 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrument-Assisted Soft Tissue Mobilization (IASTM)
Number of subjects: 23
Study 33238244 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 23
Study 34197511 — intervention group
Group type: EXPERIMENTAL
Intervention: Acknowledging the link between climate change and agricultural production in outreach mailings
Number of subjects: 10000
Study 34197511 — intervention group
Group type: EXPERIMENTAL
Intervention: Invitation to a webinar about conservation practices
Number of subjects: 10000
Study 32727619 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanfu herbal patch (SHP)
Number of subjects: 72
Study 32727619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 35646177 — intervention group
Group type: EXPERIMENTAL
Intervention: Sticky Bone (SB) technique
Number of subjects: 80
Study 35646177 — intervention group
Group type: COMPARATOR
Intervention: Bone Shell (BS) technique
Number of subjects: 80
Study 34652627 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% (20AA) compound AA injection
Number of subjects: 75
Study 34652627 — intervention group
Group type: COMPARATOR
Intervention: 8.5% (18AA‐II) compound AA injection
Number of subjects: 75
Study 34652627 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition support therapy with iso‐nitrogen and iso‐calorie
Number of subjects: 75
Study 36299407 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief face‐to‐face intervention delivered by a trained physician plus information leaflet (Intervention Group, IG)
Number of subjects: 1148
Study 36299407 — intervention group
Group type: COMPARATOR
Intervention: Simple feedback including a leaflet (Control Group, CG)
Number of subjects: 1148
Study 33706795 — intervention group
Group type: EXPERIMENTAL
Intervention: Noble metal alloy (NMA) coated BIP Foley Catheter
Number of subjects: 1000
Study 33706795 — intervention group
Group type: COMPARATOR
Intervention: Non-coated control catheter
Number of subjects: 1000
Study 32143986 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia counseling using the drawMD OB/GYN iPad™ application
Number of subjects: 72
Study 32143986 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 72
Study 32143986 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia counseling
Number of subjects: 72
Study 35341360 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-based mirror therapy (VR-MT)
Number of subjects: 54
Study 35341360 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy (COT)
Number of subjects: 54
Study 35341360 — intervention group
Group type: COMPARATOR
Intervention: Mirror therapy (MT)
Number of subjects: 54
Study 33050728 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated insulin delivery
Number of subjects: 36
Study 33050728 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy
Number of subjects: 36
Study 34346295 — intervention group
Group type: COMPARATOR
Intervention: Chitosan at 0 mg/kg concentrate
Number of subjects: 5
Study 34346295 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan at 400 mg/kg concentrate
Number of subjects: 5
Study 34346295 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan at 800 mg/kg concentrate
Number of subjects: 5
Study 34346295 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan at 1200 mg/kg concentrate
Number of subjects: 5
Study 34346295 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan at 1600 mg/kg concentrate
Number of subjects: 5
Study 32921614 — intervention group
Group type: EXPERIMENTAL
Intervention: HCA (Hypothermic Circulatory Arrest)
Number of subjects: 696
Study 32921614 — intervention group
Group type: COMPARATOR
Intervention: No HCA
Number of subjects: 696
Study 32921614 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 696
Study 616852791 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: tube voltage 100 kV; contrast agent iohexol (350 mg I/ml), reconstructed by filtered back projection
Number of subjects: 59
Study 616852791 — intervention group
Group type: COMPARATOR
Intervention: Group B: tube voltage 80 kV; contrast agent iodixanol (270 mg I/ml), reconstructed by algebraic reconstruction technique
Number of subjects: 59
Study 35802065 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation intervention based on the modified fear-avoidance model
Number of subjects: 118
Study 33896034 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced surgeons (≥ 25 mitral valve operations/year)
Number of subjects: 575
Study 33896034 — intervention group
Group type: COMPARATOR
Intervention: Less experienced surgeons
Number of subjects: 575
Study 32243576 — intervention group
Group type: EXPERIMENTAL
Intervention: O-R brush (Oral-B iO)
Number of subjects: 90
Study 32243576 — intervention group
Group type: COMPARATOR
Intervention: Sonic brush
Number of subjects: 90
Study 34282644 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month micro-video health education program
Number of subjects: 80
Study 34282644 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 80
Study 34282644 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (micro-video health education and routine care)
Number of subjects: 80
Study 33711986 — intervention group
Group type: EXPERIMENTAL
Intervention: Pastille containing four polysaccharides
Number of subjects: 0
Study 33711986 — intervention group
Group type: COMPARATOR
Intervention: Control product (Parafilm®)
Number of subjects: 0
Study 33711986 — intervention group
Group type: EXPERIMENTAL
Intervention: Pastille
Number of subjects: 0
Study 32069356 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (n=137)
Number of subjects: 602
Study 32069356 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein (n=393)
Number of subjects: 602
Study 32069356 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk protein (n=72)
Number of subjects: 602
Study 32069356 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater protein doses
Number of subjects: 602
Study 32069356 — intervention group
Group type: COMPARATOR
Intervention: Older individuals (aged 71 ± 5 y)
Number of subjects: 602
Study 32069356 — intervention group
Group type: EXPERIMENTAL
Intervention: Young individuals (aged 22 ± 3 y)
Number of subjects: 602
Study 35034345 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 25000 I.U. ODF under fed conditions
Number of subjects: 48
Study 35034345 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3 25000 I.U. oral solution under fed conditions
Number of subjects: 48
Study 35034345 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 25000 I.U. ODF under fasting conditions
Number of subjects: 48
Study 33522946 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of 500,000 IU cholecalciferol (5 capsules of 100,000 IU)
Number of subjects: 1264
Study 33522946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1264
Study 33754523 — intervention group
Group type: EXPERIMENTAL
Intervention: Underlay myringoplasty
Number of subjects: 80
Study 33754523 — intervention group
Group type: COMPARATOR
Intervention: Overlay myringoplasty
Number of subjects: 80
Study 616836595 — intervention group
Group type: EXPERIMENTAL
Intervention: Anhydrous caffeine (5 mg/kg)
Number of subjects: 24
Study 616836595 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL-drink only)
Number of subjects: 24
Study 35165382 — intervention group
Group type: EXPERIMENTAL
Intervention: Average protein (15%) intake
Number of subjects: 639
Study 35165382 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher regional DNAm at TXNIP
Number of subjects: 639
Study 33978286 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanarini Rating Scale for Borderline Personality Disorder (ZAN‐BPD)
Number of subjects: 276
Study 32720908 — intervention group
Group type: EXPERIMENTAL
Intervention: Do CHANGE 2 intervention
Number of subjects: 0
Study 35799756 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine Sulfate (200 mg orally 8 hourlies thrice a day for 5 days)
Number of subjects: 0
Study 35799756 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg orally twice a day for 5 days)
Number of subjects: 0
Study 35799756 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg orally daily on day 1, followed by 250 mg orally twice a day on days 2‐5)
Number of subjects: 0
Study 35799756 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Hydroxychloroquine, Oseltamivir, and Azithromycin
Number of subjects: 0
Study 32151803 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) at 10 mg/kg/day up-titrated to 20-30 mg/kg/day for 12 weeks
Number of subjects: 263
Study 32151803 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 30 mg/kg/day
Number of subjects: 263
Study 32151803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study 32151803 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL)
Number of subjects: 263
Study 35690256 — intervention group
Group type: EXPERIMENTAL
Intervention: Homotopic conditioning (electrical stimulation of the right index finger)
Number of subjects: 20
Study 35690256 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterotopic conditioning (electrical stimulation of the right little finger)
Number of subjects: 20
Study 35690256 — intervention group
Group type: COMPARATOR
Intervention: Unconditioned TMS (single‐pulse TMS of the left M1‐HAND)
Number of subjects: 20
Study 35690256 — intervention group
Group type: COMPARATOR
Intervention: Randomly intermixed stimulation conditions
Number of subjects: 20
Study 35690256 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked stimulation (single condition repeated five or ten times)
Number of subjects: 20
Study 33756376 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Exposure Therapy (I-PE)
Number of subjects: 119
Study 33756376 — intervention group
Group type: COMPARATOR
Intervention: Integrated Coping Skills Therapy (I-CS)
Number of subjects: 119
Study 33756376 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 119
Study 34896126 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Chlorhexidine 0.2%
Number of subjects: 354
Study 34896126 — intervention group
Group type: COMPARATOR
Intervention: Topical Natamycin 5%
Number of subjects: 354
Study 34006536 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported home exercise programme (initially one face-to-face session, then managed remotely for 6 weeks)
Number of subjects: 210
Study 34006536 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face physiotherapy (course of physiotherapy as typically provided in Sydney government hospitals)
Number of subjects: 210
Study 32817131 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil (n=261)
Number of subjects: 800
Study 32817131 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Best Supportive Care (BSC)
Number of subjects: 800
Study 32668874 — intervention group
Group type: EXPERIMENTAL
Intervention: V-shaped incision (VI) group
Number of subjects: 60
Study 32668874 — intervention group
Group type: COMPARATOR
Intervention: Blair incision (BI) group
Number of subjects: 60
Study 32668874 — intervention group
Group type: COMPARATOR
Intervention: Hairline N-shaped incision (NI) group
Number of subjects: 60
Study 36387350 — intervention group
Group type: EXPERIMENTAL
Intervention: Descurainia sophia (DS) for six weeks
Number of subjects: 53
Study 36387350 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 53
Study 36704072 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth transdiagnostic CBT (12 sessions)
Number of subjects: 12
Study 36704072 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 12
Study 33380183 — intervention group
Group type: EXPERIMENTAL
Intervention: CR-FB design
Number of subjects: 68
Study 33380183 — intervention group
Group type: EXPERIMENTAL
Intervention: PS-FB design
Number of subjects: 68
Study 33380183 — intervention group
Group type: EXPERIMENTAL
Intervention: CR-RP design
Number of subjects: 68
Study 32627722 — intervention group
Group type: EXPERIMENTAL
Intervention: Prioritized areas of research related to life after stroke
Number of subjects: 589
Study 32627722 — intervention group
Group type: COMPARATOR
Intervention: Gender differences in prioritization
Number of subjects: 589
Study 32627722 — intervention group
Group type: COMPARATOR
Intervention: Age differences in prioritization
Number of subjects: 589
Study 35365369 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour interprofessional SDM training (didactic and interactive training using video examples)
Number of subjects: 134
Study 35365369 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (CG)
Number of subjects: 134
Study 35308782 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for predicting overall survival (OS)
Number of subjects: 893
Study 35308782 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for predicting cancer-specific survival (CSS)
Number of subjects: 893
Study 35308782 — intervention group
Group type: COMPARATOR
Intervention: Nomograms compared to AJCC staging system
Number of subjects: 893
Study 35141977 — intervention group
Group type: EXPERIMENTAL
Intervention: Integra® matrix
Number of subjects: 39
Study 35141977 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelnac® matrix
Number of subjects: 39
Study 35141977 — intervention group
Group type: EXPERIMENTAL
Intervention: Matriderm® matrix
Number of subjects: 39
Study 35141977 — intervention group
Group type: COMPARATOR
Intervention: Control Group (without dermal matrix)
Number of subjects: 39
Study 34015244 — intervention group
Group type: EXPERIMENTAL
Intervention: SGS-742
Number of subjects: 19
Study 34015244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 32782077 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 140
Study 32782077 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of EMLA cream and massage
Number of subjects: 140
Study 32782077 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 140
Study 32782077 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 140
Study 34921836 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity of effort resistance training (HIT)
Number of subjects: 57